Articles from Investor Brand Network
BioMedNewsBreaks — Calidi Biotherapeutics Inc. (NYSE American: CLDI) Showcases Platform ‘Designed to Unlock New Possibilities in Cancer Therapy’
Calidi Biotherapeutics (NYSE American: CLDI) is focused on discovering more effective treatments amid projections from the American Cancer Society that 2024 will be the first year ever to see two million people diagnosed with cancer. “Calidi Biotherapeutics’ RTNova (‘CLD-400’) is an innovative systemic antitumor enveloped virotherapy designed to unlock new possibilities in cancer therapy. The platform addresses challenges presented by untargetable and untreatable metastatic diseases and offers a possible potential transformative solution with wide-ranging applications,” reads a recent article.
Via Investor Brand Network · December 3, 2024
InvestorNewsBreaks — BioAdaptives Inc. (BDPT) Announces One-for-One Stock Dividend
BioAdaptives (OTC: BDPT) today announced that its board of directors approved a dividend to all common stockholders. According to the announcement, stockholders will receive matching shares for all of their owned shares on the record date.
Via Investor Brand Network · December 3, 2024
420 with CNW — Study Finds That Adolescents Suffer More Severe Psychosis Symptoms if They Use Marijuana
A recent study by researchers from St. Louis’ Washington University has found that teenagers who use marijuana experience more signs of psychosis spectrum and higher levels of distress due to the symptoms. This suggests that both self-medication and shared vulnerability play a role in linking marijuana use to an increased risk of psychosis.
Via Investor Brand Network · December 3, 2024
TechMediaBreaks – VenHub Global Inc. Taking Smart Retail Vision to Larger Stage
VenHub, a disruptive AI and robotics company, and Target Global Acquisition I Corp. (NASDAQ: TGAA), a NASDAQ-listed special purpose acquisition company, have announced their entry into a definitive business combination agreement, dated as of Dec. 2, 2024. According to the announcement, the proposed business combination is expected to be completed in the second quarter of 2025, subject to customary closing conditions, including regulatory and shareholder approvals. Following the closing, the combined company will operate as VenHub Global Holdings, Inc. and is expected to list on Nasdaq under the ticker symbol VHUB.
Via Investor Brand Network · December 3, 2024
Adageis Is ‘One to Watch’
Adageis is a healthcare technology company dedicated to revolutionizing patient care through innovative solutions. By integrating artificial intelligence (“AI”) and machine learning, Adageis addresses inefficiencies in healthcare delivery, enabling providers to enhance patient outcomes and streamline operations. The company focuses on leveraging advanced technology to meet the growing demand for value-based care and quality incentives in the healthcare sector.
Via Investor Brand Network · December 3, 2024
Judge Halts Upcoming Minnesota Marijuana Business License Lottery
Last week, a judge in Ramsey County stopped a lottery that would’ve awarded marijuana licenses in Minnesota. This is a huge setback for regulators in the state, who are prepping for legal sales come 2025.
Via Investor Brand Network · December 3, 2024
InvestorNewsBreaks – Trump Media & Technology Group Corp. (NASDAQ: DJT) CEO Applauds Kash Patel’s FBI Nomination: ‘A Light to Restore Trust in the Bureau’
Trump Media & Technology Group (NASDAQ: DJT) is making headlines with its CEO, Devin Nunes, congratulating board member Kash Patel on his nomination as FBI Director by President-elect Trump. Nunes commends Patel’s legal and investigative skills, emphasizing his commitment to the Constitution and his efforts to uncover alleged misconduct in the Intelligence Community. TMTG is recognized for its platforms like Truth Social and Truth+, which focus on free speech and family-friendly content.
Via Investor Brand Network · December 3, 2024
TechMediaBreaks – HUB Cyber Security Ltd. (NASDAQ: HUBC) Reports Half-Year 2024 Results, Demonstrates Strong Turnaround and Growing Demand for Secured Data Fabric Solutions
HUB Cyber Security (NASDAQ: HUBC) (“HUB Security”) reported revenue of $15.7 million for H1 2024, down from $25.0 million in H1 2023, reflecting a strategic shift away from less profitable segments. Despite the revenue decrease, the company improved its gross margin to 9.5%, up from -7.6% in the prior year, due to a focus on higher-margin areas. Operating expenses were significantly reduced by 71%, and the operating loss decreased by 74%. HUB is positioning itself for future growth with its Secured Data Fabric platform, which consolidates data securely and is gaining strong traction across industries, particularly in financial institutions. The company’s strategic restructuring and focus on its innovative solutions are expected to drive continued growth, with projected revenue increases in H2 2024. HUB is also advancing its “HUB 360” approach, targeting financial institutions with high-margin opportunities.
Via Investor Brand Network · December 3, 2024
GreenCarNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Recognizes Revenue from Follow-On Order of Bollinger B4 Trucks by TEC Equipment
Mullen Automotive (NASDAQ: MULN) announced a follow-on order from TEC Equipment for seven all-electric 2025 Bollinger B4 trucks, with revenue recognized in the current fiscal quarter. This order builds on TEC’s initial purchase of three B4 trucks in October 2024, with deliveries planned across California, Oregon, and Washington. The Class 4 B4 truck, featuring a 185-mile range and 7,394-pound payload, is designed for commercial fleets with a focus on safety and efficiency, qualifying for substantial federal and state tax incentives. Bollinger Motors has recently achieved key milestones, including EPA and CARB certifications, production launch, and agreements with major fleet operators and dealers, solidifying its position in the commercial EV market.
Via Investor Brand Network · December 3, 2024
RockBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Subsidiary Secures Key Environmental Approval for Los Azules Copper Project
McEwen Mining (NYSE: MUX) (TSX: MUX), through its subsidiary McEwen Copper Inc., has achieved a significant milestone with the approval of the Environmental Impact Assessment (“EIA”) for its Los Azules copper project in Argentina. Granted by the San Juan Provincial Government’s Ministry of Mines, the approval reflects McEwen Mining’s commitment to sustainable practices and positions the project for feasibility studies, construction, and operation. Designed for renewable energy use and carbon neutrality by 2038, Los Azules reinforces McEwen Mining’s leadership in modern, environmentally responsible mining. A definitive feasibility study is anticipated in early 2025, with construction potentially beginning in 2026.
Via Investor Brand Network · December 3, 2024
BioMedNewsBreaks — Kairos Pharma Ltd. (NYSE American: KAPA) Expands Phase 2 Trial of ENV105 to City of Hope for Prostate Cancer Therapy
Kairos Pharma (NYSE American: KAPA) announced the inclusion of City of Hope Cancer Center in California in its Phase 2 clinical trial for ENV105, targeting castrate-resistant prostate cancer. The trial, supported by Kairos Pharma and a National Cancer Institute grant, evaluates ENV105’s potential to overcome hormone therapy resistance in combination with apalutamide. Adding City of Hope allows for a broader patient population and the identification of biomarkers to optimize treatment. Kairos executives highlighted the strong preclinical evidence and collaboration with City of Hope’s expert oncologists as pivotal steps in developing innovative therapies for patients resistant to standard hormone treatments.
Via Investor Brand Network · December 3, 2024
BioMedNewsBreaks — Telomir Pharmaceuticals (NASDAQ: TELO) Unveils Breakthrough Preclinical Results in Type 2 Diabetes Treatment
Telomir Pharmaceuticals (NASDAQ: TELO) announced preclinical findings showcasing the transformative potential of its molecule, Telomir-1, in reversing key parameters of Type 2 diabetes. The study demonstrated significant reductions in fasting glucose levels, improvements in glucose homeostasis, and near pre-diabetic levels of insulin resistance, supported by reduced HOMA-IR values and increased survival rates. Telomir-1’s novel mechanism targets iron metabolism, addressing oxidative stress and beta-cell damage, setting it apart from current symptom-focused diabetes treatments. Telomir plans to expand research into other chronic and age-related diseases, including Alzheimer’s and osteoarthritis, as part of its mission to address root causes of disease.
Via Investor Brand Network · December 3, 2024
Musk’s Support for Trump is Turning Tesla Owners Against the Brand
Elon Musk’s endorsement of Donald Trump’s presidential bid and his continued support of the controversial businessman turned politician is turning Tesla owners against the electric vehicle brand . Once loved by liberals who championed Tesla’s eco-friendly objectives, the Texas-maker has drawn plenty of ire from the Left in recent weeks due to its CEO’s political leanings.
Via Investor Brand Network · December 3, 2024
Codelco Ramps Up Copper Production to Attain 2024 Targets
Codelco, a copper mining firm owned by the government of Chile has increased its production in an effort to meet this year’s targets. Copper is a critical metal, given its use in the green energy revolution and the increase in use of electric vehicles.
Via Investor Brand Network · December 3, 2024
SEC Includes ESG in Its Risk Warning to Fund Managers
Last month, the United States Securities and Exchange Commission broadcasted a risk alert that warned fund managers of problems flagged during audits. The alert, which centered on a number of areas, also highlighted that ESG was an area of focus for the commission and reflects the shift in sustainability reporting.
Via Investor Brand Network · December 3, 2024
e-Commerce Sees New Record as Thanksgiving Shoppers Go All Out on Spending
2024 saw Thanksgiving sales increase, with mobile and e-commerce purchases hitting new highs. An analysis conducted by Adobe Analytics determined that by the end of November 28 th, online consumers had spent $6.1 billion during Thanksgiving. This figure represents an 8.8% increase from 2023’s Thanksgiving sales.
Via Investor Brand Network · December 3, 2024
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Highlights Expanding Opportunities in GLP-1 Drug Market and Strategic Focus on DehydraTECH Integration
Lexaria Bioscience (NASDAQ: LEXX, LEXXW) provided a strategic update on its efforts to leverage its DehydraTECH technology within the rapidly growing GLP-1 drug market, projected to surpass $100 billion annually. GLP-1 drugs, initially approved for diabetes and weight loss, are now being explored for broader applications, including cardiovascular, liver, and kidney diseases, as well as sleep apnea and neurodegenerative conditions. Lexaria is advancing research to enhance GLP-1 drug delivery to the brain, with data from its animal study on brain absorption expected by early 2025. The company aims to capitalize on the transformative potential of GLP-1 drugs by enabling expanded therapeutic benefits and improved efficacy through its proprietary technology.
Via Investor Brand Network · December 3, 2024
MiningNewsBreaks – Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Boosts Production with Successful Tubing Operation at SASB Gas Field
Trillion Energy (CSE: TCF) (OTCQB: TRLEF) has completed the installation of 2 3/8 velocity string tubing in four wells at the SASB Gas Field in Turkey, including three long-reach wells on the Akcakoca Platform. This operation aims to reduce water loading and enhance gas production by enabling wells to produce at lower wellhead pressures. Initial results show steady production improvements from Guluc-2 and West Akcakoca-1, while Akcakoca-3 continues with reduced water output. The next phase includes similar upgrades to two tripod wells, reservoir stimulation, and optimized choke adjustments to maximize gas recovery. Despite winter delays, Trillion anticipates a significant boost in overall well performance.
Via Investor Brand Network · December 3, 2024
TechMediaBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Announces Integration with X Corp. to Revolutionize Digital Advertising
Thumzup Media Corp. (NASDAQ: TZUP) plans to integrate its innovative ad tech platform with X Corp. (formerly Twitter), expanding its reach to over 535 million monthly active users. This integration, expected by January 2025, complements Thumzup’s existing presence on Instagram, allowing unified campaign management, enhanced audience targeting, and user monetization through authentic brand endorsements. CEO Robert Steele highlighted the milestone as part of Thumzup’s aggressive growth strategy following its Nasdaq listing and $250,000 in user payouts for 25,000 Instagram posts. The integration will enable Thumzup to explore diverse advertising content unique to X, driving scalable, authentic engagement in the booming $1 trillion digital ad market.
Via Investor Brand Network · December 3, 2024
D-Wave Quantum Inc. (NYSE: QBTS) Completes Q3 2024 with Key Product Milestones, New Partnerships and Technological Breakthroughs
D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, recently announced Q3 2024 business results, highlighting several key operational milestones and technological achievements, including new partnerships and developments in driving the adoption of quantum computing technology.
Via Investor Brand Network · December 3, 2024
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Expands Leadership Team to Support TNX-102 SL Launch
Tonix Pharmaceuticals (NASDAQ: TNXP) has strengthened its leadership team with the appointments of Bradley Raudabaugh as Vice President of Marketing and Errol Gould, Ph.D., as Vice President of Medical Affairs, to prepare for the anticipated launch of TNX-102 SL for fibromyalgia. Raudabaugh brings extensive expertise from leading product launches at Axsome Therapeutics and other top pharmaceutical companies, while Dr. Gould offers over 25 years of experience in medical affairs and research across neurology, pain, and sleep therapeutics. These strategic hires aim to enhance Tonix’s commercial strategies and build its reputation in the medical community as the company awaits the FDA decision on TNX-102 SL in 2025.
Via Investor Brand Network · December 3, 2024
What the Allegations Against Adani Group Suggest About India’s Renewable Energy Push
The U.S. recently charged Adani Group founder Gautam Adani with bribery and fraud allegations in one of the most significant challenges Adani Group has faced since its founding. As Adani is a key player in India’s energy sector and was one of the companies expected to aid the Asian country’s transition to clean energy, the charges paint a poor picture of India’s renewable energy drive.
Via Investor Brand Network · December 3, 2024
New York is Poised to Greenlight XRP-Issued Stablecoin
New York’s financial regulatory authority is reportedly close to approving a new stablecoin from Ripple. According to sources familiar with the matter, the New York Department of Financial Services (NYDFS) has indicated that Ripple’s stablecoin, RLUSD, is on track for approval, with a potential launch date set for December 4.
Via Investor Brand Network · December 3, 2024
Riley Sees Additional Financial Advisors Exiting the Firm
Riley Financial Inc. (NASDAQ: RILY), a leading investment bank, has faced a tough year with its stock price dropping by more than 68% . The dramatic decline reflects major struggles, including financial challenges, advisors leaving, and increased regulatory scrutiny. Several experienced financial advisors have chosen to leave B. Riley for its competitors in recent months.
Via Investor Brand Network · December 3, 2024
Annovis Bio Inc. (NYSE: ANVS) to Present Recent Achievements and 2025 Strategic Outlook During Upcoming Live Investor Webcast
Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), will hold a live investor webcast on Dec. 11, 2024, at 4:30 p.m. EST, to provide key operational highlights and year-end clinical updates ( https://ibn.fm/69VpQ ).
Via Investor Brand Network · December 3, 2024